Review Series

February 2023: Acute Myeloid Leukemia

Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges (1497 Online Views)

Richard F. Schlenk

https://doi.org/10.3324/haematol.2022.280803

The clinical impact of the molecular landscape of acute myeloid leukemia (3082 Online Views)

Sabine Kayser, Mark J. Levis

https://doi.org/10.3324/haematol.2022.280801

New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia (2703 Online Views)

Razan Mohty, Rama El Hamed, Eolia Brissot, Ali Bazarbachi, Mohamad Mohty

https://doi.org/10.3324/haematol.2022.280798

Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question (1855 Online Views)

Sonia Jaramillo, Richard F. Schlenk

https://doi.org/10.3324/haematol.2022.280802

Leukemic stem cells and therapy resistance in acute myeloid leukemia (2485 Online Views)

Patrick Stelmach, Andreas Trumpp

https://doi.org/10.3324/haematol.2022.280800

December 2022: Measurable Residual Disease

Introduction to the Series on Measurable Residual Disease (1214 Online Views)

Jerry Radich

https://doi.org/10.3324/haematol.2022.281079

Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients (2986 Online Views)

Caner Saygin, Joseph Cannova, Wendy Stock, Lori Muffly

https://doi.org/10.3324/haematol.2022.280638

Measurable residual disease in chronic myeloid leukemia (1362 Online Views)

Susan Branford, Jane F. Apperley

https://doi.org/10.3324/haematol.2022.281493

The present and future of measurable residual disease testing in acute myeloid leukemia (3090 Online Views)

James S. Blachly, Roland B. Walter, Christopher S. Hourigan

https://doi.org/10.3324/haematol.2022.282034

June 2022: Treatment of thrombocytopenias

Introduction to a review series on the treatment of thrombocytopenic disorders: something old, something new (1696 Online Views)

Francesco Rodeghiero

https://doi.org/10.3324/haematol.2022.280920

Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies (8539 Online Views)

David J. Kuter

https://doi.org/10.3324/haematol.2021.279512

Treatment of drug-induced immune thrombocytopenias (4322 Online Views)

Irene Marini, Gunalp Uzun, Kinan Jamal, Tamam Bakchoul

https://doi.org/10.3324/haematol.2021.279484

Treatment of inherited thrombocytopenias (2297 Online Views)

Carlo L. Balduini

https://doi.org/10.3324/haematol.2022.280856

January 2022: Indolent lymphomas

Indolent lymphomas: introduction to a series highlighting progress and ongoing challenges (2154 Online Views)

Sonali M. Smith, Gilles Salles

https://doi.org/10.3324/haematol.2021.280218

Time for an individualized approach to first-line management of follicular lymphoma (6992 Online Views)

Guillaume Cartron, Judith Trotman

https://doi.org/10.3324/haematol.2021.278766

Prospects in the management of patients with follicular lymphoma beyond first-line therapy (9013 Online Views)

David Qualls, Gilles Salles

https://doi.org/10.3324/haematol.2021.278717

Marginal zone lymphoma: present status and future perspectives (20039 Online Views)

Chan Y. Cheah, Emanuele Zucca, Davide Rossi, Thomas M. Habermann

https://doi.org/10.3324/haematol.2021.278755

What about you?

Tell us your interest and get all the new contents of haematologica in advance.

GET NOW